Purine synthesis enzyme

Purine synthesis enzymes comprise a group of metabolic enzymes responsible for the de novo biosynthesis of purine nucleotides, which are the essential building blocks of DNA and RNA. This multi-step process begins with phosphoribosyl pyrophosphate formation and includes numerous ATP-dependent reactions catalyzed by distinct enzymes (PRPP synthetase, PRPP amidotransferase, glycinamide ribonucleotide synthetase, etc.), ultimately producing inosine monophosphate (IMP) as the precursor to AMP and GMP. These enzymes are tightly regulated, as nucleotide imbalance can increase mutation rates and cellular dysfunction. Dysregulation and genetic defects in purine synthesis can lead to diseases such as cancer, gout, and immunodeficiency. Because they are central to DNA and RNA synthesis, these enzymes are attractive targets for cancer chemotherapy and immunosuppressive treatments.

Other names

Purine biosynthetic enzymesde novo purine synthesis enzymespurine metabolic pathway enzymes

Enzyme inhibition (blocking key pathway steps to prevent nucleotide formation); Competitive substrate inhibition (purine analogs are integrated into the pathway, resulting in dysfunctional nucleotides)